Plasma protein extravasation induced in the rat dura mater by stimulation of the parasympathetic sphenopalatine ganglion.
It has been proposed that migraine could result from a neurogenic inflammation of the dura mater. According to this theory, inflammation could be initiated by an axon reflex of nociceptive nerve fibers, but the trigger of this axon reflex remains poorly understood. Previous works have shown that parasympathetic agonists can activate mast cells and/or sensory C-fibers, inducing pain and inflammation. The aim of the present work was to determine whether the activation of intracranial parasympathetic nerve fibers could trigger an inflammatory mechanism within the rat dura mater. Activation of the intracranial parasympathetic system was achieved by electrical stimulation of the sphenopalatine ganglion (SPG). The development of a neurogenic inflammation was estimated either by microscopic examination or by quantitative measurement of plasma protein extravasation (PPE) in the dura. To determine the respective roles of the parasympathetic and sensory innervations, two groups of rats were pretreated either with atropine or with capsaicin. Stimulation of the SPG induced a PPE increase of about 200% in the stimulated side on the dura mater. Extravasated material was mainly concentrated around small blood vessels. This extravasation was significantly reduced by capsaicin pretreatment and completely abolished by atropine. Infusion of carbachol in the common carotid artery induced PPE in the ipsilateral dura comparable to that induced by electrical stimulation of the SPG. This extravasation was also blocked by atropine infusion. These data indicate for the first time that the parasympathetic nervous system can trigger a neurogenic inflammation in the dura via muscarinic cholinergic receptors. Sensory C-fibers seem to play a role in this phenomenon. With respect to the potential autonomic imbalance described in the etiology of various types of vascular headaches, such a mechanism could be important in inducing attacks.
Delépine
L
L
Laboratoire de Pharmacologie et de Physiopathologie Vasculaire, CNRS ESA 5017, Université Bordeaux II, France.
Aubineau
P
P
D000109:Acetylcholine / Q000502:physiology; D000344:Afferent Pathways / Q000503:physiopathology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001369:Axons / Q000502:physiology; D001794:Blood Pressure / Q000187:drug effects; D001798:Blood Proteins / Q000378:metabolism*; D015740:Calcitonin Gene-Related Peptide / Q000378:metabolism; D002211:Capsaicin / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology / Q000633:toxicity; D004195:Disease Models, Animal; D004388:Dura Mater / Q000098:blood supply* / Q000473:pathology; D004558:Electric Stimulation; D005122:Exudates and Transudates / Q000378:metabolism*; D005726:Ganglia, Parasympathetic / Q000503:physiopathology*; D007249:Inflammation; D007269:Injections, Intra-Arterial; D008297:Male; D008881:Migraine Disorders / Q000503:physiopathology*; D009475:Neurons, Afferent / Q000378:metabolism / Q000502:physiology*; D017777:Parasympathetic Fibers, Postganglionic / Q000187:drug effects / Q000502:physiology*; D010277:Parasympathomimetics / Q000494:pharmacology / Q000633:toxicity; D010539:Permeability; D051381:Rats; D017207:Rats, Sprague-Dawley; D011976:Receptors, Muscarinic / Q000187:drug effects / Q000502:physiology*; D012710:Serum Albumin, Bovine / Q000493:pharmacokinetics; D013373:Substance P / Q000037:antagonists & inhibitors
D001798:Blood Proteins; D010277:Parasympathomimetics; D011976:Receptors, Muscarinic; D012710:Serum Albumin, Bovine; D013373:Substance P; D001285:Atropine; D002217:Carbachol; D015740:Calcitonin Gene-Related Peptide; D000109:Acetylcholine; D002211:Capsaicin